Introduction
The abortificient properties of prostaglandins have been publicized widely in both the medical and the lay press because they have been reported to be successful Filshie, 1970, 1972) as well as safe. The existence of such an effective medical method for terminating pregnancy would argue against the continued use of surgical techniques, with their disadvantages of trauma, haemorrhage, and secondary infection. Other workers, however, have not been able entirely to confirm these reports of the efficacy of prostaglandins for termination in either early or mid-pregnancy (Wiqvist and Bygdeman, 1970; Roberts et al., 1971) . Further trials are urgently needed to establish the best role for these potent drugs in clinical practice.
The intravenous administration of prostaglandins has been most extensively investigated to date. Although generally successful, its disadvantages are that it causes nausea, vomiting, and phlebitis and that in some cases the induction-abortion interval is prolonged. In an attempt to minimize or even eliminate systemic side effects other routes of administration have been tried, including transcervical extra-amniotic injection (Wiqvist and Bygdeman, 1970; Embrey and Hillier, 1971; Roberts et al., 1971) . Recently the successful use of a single transabdominal intra-amniotic injection of prostaglandins for the induction of mid-pregnancy abortion was reported by Karim and Sharma (1971) . The results of a similar trial in Cardiff are now presented, including some data obtained by recording myometrial contractility. Plasma oestrogens and progesterone were also measured in some of these patients and the results will be published in a separate report (Symonds et al., 1972 Prostaglandin E2 was used in the next 13 cases, a different regimen being followed (by request of the manufacturers). This consisted of an initial injection of 1 mg (1 mg/ml) followed by two further 1-mg doses at 10-minute intervals. Because uterine activity diminished in some patients (Cases 18, 21, 23, 25 , and 26) further 3-mg intra-amniotic injections were given (see Table II ). In all patients pulse rate, blood pressure, and body temperature were recorded every four hours and analgesic drugs were prescribed when required. Intravenous oxytocin infusions were used when pregnancy could not be terminated with prostaglandins alone. Hysterotomy was performed only when all the "medical" methods had failed.
A complete record of amniotic fluid pressure changes was obtained from only two patients (Cases 1 and 5). Transient blockage of the cannula was common so that many tracings were intermittent, and in other cases monitoring was discontinued on ethical grounds because induction of abortion was proving so prolonged.
Results
A single intra-amniotic injection of 25 mg of prostaglandin F2ca successfully terminated pregnancy in only six out of 14 cases, the average induction-delivery interval being 19 hours 31 minutes (Table I ). In a further six patients cervical dilation had reached 2 cm after intervals varying from 24 to 48 hours, and intravenous oxytocin infusions were then required to stimulate effective uterine activity. In this group the average induction-abortion interval was 59 hours, being particularly prolonged in primigravidae. Two patients (Cases 6 and 14) failed to abort at all. The cervix remained tightly closed despite further attempts to augment uterine activity by injecting hypertonic saline into the amniotic sac and giving additional intravenous infusions of oxytocin. Hysterotomy had to be performed in both these cases. Abortion was incomplete in seven of the 12 patients who were delivered vaginally.
In patients given prostaglandin E, the success rate was much With prostaglandin F,2a the primigravid patients had a particularly high failure rate, prolonged induction-delivery times, and a high incidence of incomplete abortion (Tables III  and IV) . With prostaglandin E2, however, the parity of the patient seemed to have little effect on the outcome as there was generally a successful result. Before the intra-amniotic injection of prostaglandin, no uterine activity was noted (Fig. 1) . Either immediately or, more commonly, 15 minutes after the injection, a burst of uterine activity occurred, characterized by rapidly increasing uterine tone associated with frequent small uterine contractions. In the patients who were both monitored and aborted successfully regular contractions of increasing strength became superimposed on the increased uterine tone (Fig. 2) , which persisted up to the time of abortion at a level of between 12 and 50 mm Hg. In other patients uterine activity waned (Fig. 3 ) and the contractions disappeared after a varying time interval. In the two cases in which the uterine activity was monitored during the whole induction-abortion interval (Cases 1 and 5) the entire record was divided into 10 equal phases or time intervals. In each phase, the average strength of contractions (represented by the peak amplitudes above the baseline) was measured in mm Hg and the average frequency was recorded as the number of contractions occurring in 10 minutes. Initially, uterine contractions were very frequent and of small amplitude, but as the abortion proceeded the frequency fell and the intensity increased, reaching levels between 88-7 and 110 mm Hg (Figs 4 and 5) . 
Discussion
The results of this study have been disappointing compared with those reported by Karim and Sharma (1971) . In their series of 10 cases (three treated with prostaglandin F2O and seven with prostaglandin E2) the injection-abortion interval ranged from 4j to 18 (mean 11 4) hours. In our study prostaglandin F2, alone was successful in only six out of 14 cases, with an average induction-delivery interval of nearly 20 hours. In a further six cases intravenous oxytocin was used, with a resultant average induction-delivery interval of 59 hours, and in two cases hysterotomy was required. With prostaglandin E2 the results were much better, 11 out of 13 patients (840/%) being delivered, with an average induction-abortion interval of 18 hours 41 minutes. The total dosage of prostaglandin E. used in most of our cases was 3 mg, whereas Karim and Sharma (1971) gave a single injection of 5 mg. There was a high incidence of incomplete abortion in both groups, but it was twice as high with prostaglandin F2oc (60%) as with prostaglandin E, (30%).
The trends in uterine activity after intra-amniotic prostaglandin injection, with an initial noticeable increase and then a fall in frequency of contractions coupled with a steady increase in the strength of contractions to very high peak pressures between 88 and 110 mm Hg, were quite different from those seen in normr.al labour at term. They were, however, very similar to those found during abortion induced by the intra-amniotic injection of hypertonic saline (Turnbull and Anderson, 1965) . The similarity between the pattern of uterine contractions induced by the two methods lends support to the idea that the hypertonic saline techniques may act by liberating prostaglandins within the uterus. Symonds et al. (1972) suggested that prostaglandins injected into the amniotic sac probably cause abortion by a direct effect on the myometrium because they could not find any difference in the trends in plasma oestrogen or progesterone levels between patients who aborted and those who did not. The main difference between the patterns of contractility induced by hypertonic saline and by prostaglandins injected into the amniotic sac is the high resting tone in cases treated with prostaglandins; this may just mean that much more prostaglandin reaches the myometrium in the latter group. In the doses we have used prostaglandins injected into the amniotic sac do appear to cause considerable overstimulation of the uterus, judging by the severe pain experienced by the patients, which seems to be associated with the development ofhypertonus.
Intra-amniotic administration of prostaglandins holds the great potential advantage that therapeutic abortion may be induced by a single injection. It was disappointing to find in cases treated with prostaglandin F,a, however, that despite high initial uterine activity and the development of strong regular contractions, in over half the cases the gestational sac was not aborted, for the contractions gradually lessened and then ceased. We do not know why uterine activity waned in some cases and not in others. Possibly in the patients who failed to abort tachyphylaxis developed (Embrey and Hillier, 1971) , or perhaps the prostaglandins were being rapidly metabolized to inert compounds. If so, synthetic prostaglandin analogues more resistant to metabolic breakdown might prove extremely effective. So far as the action of the prostaglandins available at present is concerned the myometrium may be more responsive to repeated small doses. The much higher success rate with prostaglandin E2 was possibly due in part to the intermittent dosage regimen, although this prostaglandin is a much more potent oxytocic agent than prostaglandin F,% (Roberts and Turnbull, 1971) . The use of larger intra-amniotic doses of either drug is limited by the severe pain caused with this method of administration.
Every method of terminating second-trimester pregnancy has serious disadvantages. Much morbidity could be avoided by speeding up referral and assessment to enable most terminations to be performed safely early in pregnancy, perhaps on an outpatient basis (Lewis et al., 1971) . Nevertheless, many patients requiring therapeutic abortion will continue to present in the second trimester, and in our experience so far intra-amniotic injection of prostaglandin E2 may prove to be valuable in such cases. Intra-amniotic injection of prostaglandin Foc has given disappointing results and we do not propose to continue its use. More work is required to establish the optimum dosage for intra-amniotic administration ofprostaglandin E,2 and to improve the results with intravenous and extra-amniotic injection of prostaglandin E, in controlled trials. Prostaglandins seem likely to provide the safest and most effective means of terminating second-trimester pregnancy, but the best method for administering them remains tantalizingly uncertain.
